Baird Downgrades Amedisys (AMED) to Underperform

Baird downgraded Amedisys (NASDAQ: AMED) from Neutral to Underperform, price target lowered from $10 to $8.00.

For an analyst ratings summary and ratings history on Amedisys click here. For more ratings news on Amedisys click here.

Shares of Amedisys closed at $10.67 yesterday, with a 52 week range of $9.12-$38.87.

---

Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!

You May Also Be Interested In

• UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
• Barclays on U.S. REITs: Best Ideas List: Adding HPP; Removing ARE
• UPDATE: Williams Financial Group Upgrades Semtech Corp. (SMTC) to Buy; Check Again...Quarter Was Fairly Strong

Create E-mail Alert Related Categories

Downgrades

Related Entities

Robert W Baird

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter